Tec is a non-receptor type tyrosine kinase which is tyrosine phosphorylated and activated upon stimulation of hematopoietic cells with various cytokines. The role of Tec in G protein-coupled receptor-and integrin-mediated signalings has not been elucidated. We therefore investigated the regulation of Tec in human blood platelets. Tec was rapidly tyrosine phosphorylated in response to platelet agonists which activate G proteincoupled receptors such as thromboxane A 2 analog (U46619), thrombin, and thrombin receptor activating peptide (TRAP). TRAP-induced phosphorylation in Tec was signi®cantly reduced under the conditions which abrogate ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation. However, TRAP induced signi®cant levels of the phosphorylation even under these conditions and also in thrombasthenic platelets which lack functional GP IIb ± IIIa molecules, suggesting that activation of G-protein-coupled receptor causes the phosphorylation. To clarify whether integrin engagement by itself causes the phosphorylation in Tec, we examined the state of the phosphorylation in platelets activated by integrin engagement. Platelet adhesion to immobilized ®brinogen or collagen induced signi®cant levels of the phosphorylation. Furthermore, Tec was translocated to cytoskeleton in response to TRAP in a manner dependent on platelet aggregation, suggesting that Tec can be a component of integrin-mediated signalings. These results collectively indicate that Tec is involved in G protein-coupled receptor-and integrin-mediated signalings in human blood platelets.
Introduction
Tec is a non-Src type cytoplasmic tyrosine kinase and is predominantly expressed in liver (Mano et al., 1990) and a wide variety of hematopoietic cells (Mano et al., 1993) . The Tec family consists of ®ve members, Tec, Btk (Tsukada et al., 1993; Vetrie et al., 1993) , Itk/Tsk/ Emt (Siliciano et al., 1992; Heyeck and Berg, 1993; Yamada et al., 1993) , Txk (Haire et al., 1994) , and Bmx (Tamagnone et al., 1994) . All of these proteins have a unique amino-terminal region consisting of a pleckstrin homology (PH) domain (with the exception of Txk) and a Tec homology (TH) domain, followed by a Src homology (SH)-3 domain, an SH-2 domain and a kinase domain. Several lines of evidence indicate that the Tec family kinases are involved in the growth, dierentiation, and activation of hematopoietic cells. Itk/Tsk/Emt, which is exclusively expressed in T lymphocytes, was reported to be activated by the stimulation of CD28 (August et al., 1994) , suggesting that Itk/Tsk/Emt is involved in the mechanism for the activation of T lymphocytes. Further, point mutations in btk gene has been reported to result in X-linked agammaglobulinemia due to the abnormality in B cell development (Vetrie et al., 1993) .
Although its exact role in cell growth and dierentiation has not been elucidated, Tec kinase becomes phosphorylated in tyrosine residues and activated upon stimulation with various cytokines such as stem cell factor (SCF) (Tang et al., 1994) , granulocyte colony-stimulating factor (G-CSF) , interleukin-6 (IL-6) (Matsuda et al., 1995) , erythropoietin (EPO) (Machide et al., 1995) , interleukin-3 (IL-3) , and thrombopoietin (TPO) . Upon cytokine stimulation, Tec associates with gp 130, a signal transducer of the IL-6 family (Matsuda et al., 1995) , and c-kit (Tang et al., 1994) . Furthermore, it has been revealed that Tec links cytokine receptors to phosphatidylinositol 3-kinase through JAKs (Janus kinases) (Takahashi-Tezuka et al., 1997) . Thus, it is highly possible that Tec plays an important role in cytokinemediated signalings.
Blood platelets are terminally dierentiated unnucleated cells which exert hemostatic function by rapid secretion, aggregation, and adhesion in response to various agonists such as adenosine 5'-diphosphate (ADP), thrombin, and collagen. ADP and thrombin mediate signalings for platelet activation through G protein-coupled receptors, whereas collagen by platelet integrin GP Ia ± IIa and GP VI. It is believed that protein tyrosine kinases, which in nucleated cells mediate intracellular signaling mainly for cell growth and dierentiation, play important roles in the process of platelet activation (Dhar et al., 1990; Salari et al., 1990; Shattil et al., 1992; Schoenwaelder et al., 1994) . To date, Src (Horvath et al., 1992; Oda et al., 1992; Clark and Brugge, 1993) , Syk (Clark et al., 1994a) and FAK (Lipfert et al., 1992; Shattil et al., 1994) kinases have been reported to be involved in the process of platelet activation. In the present study, we proved that Tec is involved not only in cytokine receptor-mediated signaling but also in G proteincoupled receptor-and integrin-mediated signalings in human blood platelets.
Results

Tec is rapidly phosphorylated on tyrosine during platelet activation
To determine whether Tec is tyrosine phosphorylated during platelet activation, we stimulated gel-®ltrated platelets with various agonists without stirring, after which Tec was immunoprecipitated and its phosphorylation was detected by immunoblotting using antiphosphotyrosine antibody. As shown in Figure 1a , thrombin, collagen, thromboxane analog (U46619) and TPO induced signi®cant levels of tyrosine phosphorylation in Tec. Thrombin-induced tyrosine phosphorylation in Tec was not inhibited by preincubation with aspirin, which irreversibly inhibits cyclooxygenase, or apyrase, which dephosphorylates ADP (data not shown), suggesting that secondary agonists were not required for the phosphorylation. In the following experiments we used thrombin receptor activating peptide (TRAP) (Rasmussen et al., 1993; Vassallo et al., 1992) instead of thrombin to speci®cally activate the G protein-coupled seven transmembrane thrombin receptor (Vu et al., 1991) . We then observed the time course of TRAP-induced tyrosine phosphorylation under stirring conditions which allow platelet aggregation ( Figure 1b) . When platelets were stimulated with 30 mM of TRAP, tyrosine phosphorylation in Tec was observed at as early as 15 s (the earliest time point measured), and reached a maximal level within 2 ± 4 min. Thus, phosphorylation of Tec starts at an early stage of platelet activation. However, it took a relatively long time to reach the maximal level. As platelet aggregation completed within 2 min of TRAP addition, the result shows the possibility that fibrinogen binding to GP IIb ± IIIa and subsequent platelet aggregation are required for the maximal levels of the phosphorylation.
Ligand binding to GP IIb ± IIIa augments TRAP-induced tyrosine phosphorylation in Tec
To clarify the role of ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation, platelets were activated by TRAP either under non-stirring condition, which does not allow platelet aggregation, or in the presence of RGDS peptide, which prevents ligand binding to GP IIb ± IIIa as well. As shown in Figure  2a , when platelets were activated under the conditions which inhibit platelet aggregation, levels of the phosphorylation decreased signi®cantly (lanes 4 and 5). The results indicate that ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation were required for the maximal levels of the phosphorylation. However, we still observed signi®cant levels of the phosphorylation even under the conditions which abrogate ligand binding to GP IIb ± IIIa. To further clarify whether ®brinogen binding to GP IIb ± IIIa is essential for TRAP-or collagen-induced tyrosine phosphorylation in Tec, we assayed the phosphorylation of Tec in thrombasthenic platelets which lack functional GP IIb ± IIIa molecules. As shown in Figure  2b , both TRAP and collagen induced signi®cantly decreased but clearly detectable levels of the phosphorylation comparing with those in normal control. Thus, we conclude that although ®brinogen binding to GP IIb ± IIIa augments TRAP-or collagen-induced tyrosine phosphorylation in Tec, intracellular evens directly associated with the activation of thrombin or collagen receptor alone are sucient to induce the phosphorylation.
Integrin engagement induces tyrosine phosphorylation in Tec
It is now believed that tyrosine phosphorylation is involved in integrin-mediated signaling (Clark and Brugge, 1995) . Some of the signaling molecules in platelets have been reported to be tyrosine phosphorylated in a manner dependent on the engagement of platelet integrins such as GP IIb ± IIIa and GP Ia ± IIa Platelet aggregation was assayed concomitantly (Kornberg et al., 1991; Haimovich et al., 1993) . Because ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation signi®cantly augmented TRAPinduced tyrosine phosphorylation in Tec, we examined whether ligand binding to platelet integrins by itself causes tyrosine phosphorylation in Tec by assaying the state of the phosphorylation after platelet adhesion to immobilized ®brinogen or collagen ( Figure 3 ). In comparison with platelets exposed to immobilized albumin (lane 1), adhesion to immobilized ®brinogen (lane 2) or collagen (lane 3) induced signi®cant levels of the phosphorylation. As it was previously reported that tyrosine phosphorylation in FAK (Haimovich et al., 1993) and Vav (Cichowski et al., 1996) induced by ®brinogen binding to GP IIb ± IIIa was dependent on ADP, we examined the role of ADP in integrinmediated phosphorylation in Tec. As shown in lanes 5 and 6, ADP scavenger, apyrase, hardly aected the levels of the phosphorylation in Tec. In this experiment we con®rmed the eect of apyrase by observing under microscopy the inhibition of platelet spreading induced by binding to immobilized ®brinogen.
Tec is translocated to cytoskeleton by stimulation with TRAP
One possible mechanism by which platelet cytoskeleton regulates signal transduction is to localize signaling molecules in cytoskeleton. Among tyrosine kinases, Src (Horvath et al., 1992; Oda et al., 1992; Clark and Brugge, 1993) , Syk (Clark et al., 1994a) and FAK (Lipfert et al., 1992) have been reported to be translocated to cytoskeleton upon platelet aggregation.
To determine whether Tec is also translocated, subcellular fractions of quiescent and activated platelets were prepared as described in Materials and methods, and the translocation of Tec to cytoskeleton was detected by quantitative immunoblotting. Figure 4 shows the representative result of four independent experiments. After stimulation with TRAP under stirring condition, Tec was translocated to cytoskeleton (lane 4). Subcellular distribution of Tec in these four experiments was analysed by densitometry. As shown in Table 1 , approximately 10% of total cellular Tec was translocated from soluble to cytoskeletal fractions during platelet aggregation. As the translocation of Src, Syk and FAK have been reported to be dependent on platelet aggregation, we examined whether it is also the case for the translocation of Tec to cytoskeleton. When platelets were activated by TRAP under the conditions which do not allow platelet aggregation (non-stirring conditions or in the presence of RGDS peptide), translocation of Tec to cytoskeleton was completely abolished (data not shown). The results clearly indicate that platelet aggregation is a prerequisite for the translocation of Tec to cytoskeleton.
Actin polymerization is not required for tyrosine phosphorylation in Tec
Actin polymerization is an intracellular event that should occur as the consequence of platelet aggregation or integrin-mediated platelet activation (Hartwig, 1992) . To understand the relationship between Tec phosphorylation and actin polymerization, we activated platelets by thrombin under stirring conditions in Fbg Fbg Figure 3 Tyrosine phosphorylation of Tec induced by platelet adhesion to immobilized ®brinogen or collagen. Gel-®ltrated platelets were pretreated at RT for 20 min with either control solvent (lanes 1 ± 3) or 5 U/ml apyrase (lanes 4 ± 6). The platelets were reacted with immobilized BSA (lanes 1 and 4), ®brinogen (lanes 2 and 5) or collagen (lanes 3 and 6) as described in Materials and methods. After 1 h incubation at RT, ®brinogen-or collagen-adherent platelets were lysed by RIPA buer. Platelets recovered from BSA-coated plates were used as a negative control. Tec immunoprecipitated with anti-Tec antibody was separated by 7.5% SDS ± PAGE, and immunoblotted with anti-phosphotyrosine (ptyr) antibody (upper panel). The same membrane was reprobed with anti-Tec antibody (lower panel)
the presence or absence of cytochalasin D which inhibits actin polymerization, and assayed tyrosine phosphorylation in Tec ( Figure 5 , lanes 1 ± 5), comparing it with that in FAK ( Figure 5 , lanes 6 ± 8).
In this particular experiment, thrombin was used as an agonist because TRAP-induced platelet aggregation was considerably inhibited in the presence of cytochalasin D. In each experiments we con®rmed that treatment with cytochalasin D did not inhibit platelet aggregation, judging by aggregometer. As shown in lanes 7 and 8, tyrosine phosphorylation in FAK was completely inhibited in the presence of cytochalasin D, which is consistent with the previous report (Lipfert et al., 1992) . Contrary to this, the phosphorylation of Tec at 5 min was not aected by this treatment (lanes 4 versus 5). To rule out the possibility that actin polymerization is required only for the early phase of the phosphorylation, we also assayed Tec phosphorylation at the earlier time point (15 s). As shown in lanes 2 and 3, tyrosine phosphorylation in Tec was not aected by this treatment. These results suggest that actin polymerization is not required for tyrosine phosphorylation in Tec. We further investigated the role of actin polymerization in translocation of Tec to cytoskeleton. Pretreat of platelets with cytochalasin D did not inhibit the translocation of Tec to cytoskeleton (data not shown), suggesting that actin polymerization is not required for the translocation.
Discussion
This study has examined the role of Tec in G proteincoupled receptor-and integrin-mediated signalings in human blood platelets. Tec is a non-receptor type tyrosine kinase which has been reported to be phosphorylated on tyrosine residues upon cytokine stimulation of hematopoietic cells (Tang et al., 1994; Machide et al., 1995; Mano et al., 1995; Matsuda et al., 1995; Miyazato et al., 1996; Yamashita et al., 1996) . Based on the previous ®ndings that Tec is tyrosine phosphorylated in response to thrombopoietin (TPO) in a TPO-dependent cell line and that TPO induces tyrosine phosphorylation in multiple platelet proteins (Kojima et al., 1995) , we ®rst assayed whether Tec is tyrosine phosphorylated in response to TPO. As shown in Figure 1a , TPO induced signi®cant levels of the phosphorylation in Tec. Interestingly, physiological platelet agonists such as thrombin, collagen, and thromboxane A 2 also induced tyrosine phosphorylation in Tec (Figure 1a ). Thrombin and thromboxane A 2 are known to mediate activation signals at least in part by G protein-coupled seven transmembrane receptors. By using thrombin receptor activating peptide (TRAP) (Vassallo et al., 1992; Rasmussen et al., 1993) as an agonist, we con®rmed that direct stimulation of G protein-coupled thrombin receptor causes significant levels of the phosphorylation in Tec. Furthermore, secondary agonists such as ADP and thromboxane A 2 were not required for thrombin-induced tyrosine phosphorylation in Tec. So far, Tec has been reported to be tyrosine phosphorylated by stimulation with cytokines such as SCF (Tang et al., 1994) , G-CSF , IL-6 (Matsuda et al., 1995) , EPO (Machide et al., 1995) , IL-3 and TPO in nucleated cells. We here demonstrate for the ®rst time that Tec is also tyrosine phosphorylated in the downstream signaling pathways of the activation of G protein-coupled receptors. Activation of G protein-coupled receptors catalyzes exchange of GTP for GDP on a subunit of G proteins, which leads to the dissociation of trimeric complex and the release of Ga-GTP and Gbg subunits (Gilman, Translocation of Tec to cytoskeleton after stimulation with TRAP. Gel-®ltrated platelets were unstimulated (lanes 1 ± 3) or stimulated with 30 mM TRAP (lanes 4 ± 6) at 378C for 5 min with stirring. The reaction was stopped by adding an equal volume of 26platelet lysing buer, and then soluble (SOL), cytoskeleton (CSK) and membrane skeleton (MSK) fractions were prepared as described in Materials and methods. CSK, MSK and 1/20 diluted SOL samples were applied on 7.5% SDS ± PAGE. Tec in each of the fractions was detected by immunoblotting with anti-Tec antibody 1987; Simon et al., 1991) . Recently, activation of Ras/ mitogen-activated protein kinase (MAPK) pathway by Gbg has attracted considerable attention (Crespo et al., 1994; Faure et al., 1994; Koch et al., 1994) . Although the signaling pathway from Gbg subunits to Ras activation has not been elucidated yet, Tec kinase family proteins, Tsk and Btk, are known to be activated by Gbg subunits (Langhans-Rajasekaran et al., 1995) . Furthermore, pleckstrin homology (PH) domain of Btk was reported to interact with pertussis toxin-sensitive Gbg subunits (Tsukada et al., 1994) . As Tec kinase is a member of Tec family proteins which posses PH domain, we speculate that Tec may be also an eector of Gbg subunits. When platelets are activated by thrombin or TRAP, a rapid increase in the levels of tyrosine phosphorylation in multiple platelet proteins is observed. The phosphorylation occurs in three temporally distinct phases (Clark et al., 1994b) . The ®rst or the early phase of the phosphorylation occurs independent of fibrinogen binding to GP IIb ± IIIa. Fibrinogen binding to GP IIb ± IIIa initiates the second phase of the phosphorylation, which is followed by the third phase generated by subsequent platelet aggregation. To specify the role of tyrosine kinases involved in platelet activation, many researchers have attempted to elucidate the temporal relationship between platelet aggregation and tyrosine phosphorylation of the kinases. These three phases of the phosphorylation can be distinguished in in vitro experiments.
We then investigated whether ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation are required for the phosphorylation in Tec (Figure 2a) . We concluded that Tec is signi®cantly tyrosine phosphorylated independent of ®brinogen binding to GP IIb ± IIIa. The ®nding that Tec was tyrosine phosphorylated in response to TRAP even in thrombasthenic platelets which lack functional GP IIb ± IIIa molecules (Figure 2b ) also supports this conclusion. However, it should be also emphasized that ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation were obviously required for the maximal levels of the phosphorylation in Tec. Taken together, we believe that Tec is widely involved in the process of platelet activation, namely the early phase of platelet activation, ligand binding to GP IIb ± IIIa and subsequent platelet aggregation.
In the time course experiment shown in Figure 1b , we demonstrated that Tec starts to be tyrosine phosphorylated in the early phase of platelet activation, but it took 2 ± 4 mins to reach the maximal levels of the phosphorylation. To date, time courses of the phosphorylation in two important platelet tyrosine kinases, Syk (Clark et al., 1994a) and FAK (Lipfert et al., 1992) , have been reported. As the phosphorylation in FAK was strictly dependent on platelet aggregation (Lipfert et al., 1992) , the phosphorylation occurs after platelet aggregation. Contrary to this, Syk was reported to be tyrosine phosphorylated both in the early phase of platelet activation and after ®brinogen binding to GP IIb ± IIIa (Clark et al., 1994b) . Thus, we consider that the time course of the phosphorylation in Tec is completely dierent from both of these kinases.
Platelet integrins have been shown to mediate tyrosine phosphorylation in multiple proteins following integrin engagement (Kornberg et al., 1991; Haimovich et al., 1993) . As ®brinogen binding to GP IIb ± IIIa and subsequent platelet aggregation significantly augmented tyrosine phosphorylation in Tec, we examined whether direct stimulation of platelet integrins with immobilized ligands alone causes the phosphorylation in Tec. As shown in Figure 3 , Tec was tyrosine phosphorylated by adhesion to immobilized ®brinogen or collagen in a manner independent of ADP release. In this respect, GP IIb ± IIIa-mediated tyrosine phosphorylation in Tec is dierent from that of FAK, which has been reported to require an additional agonist, ADP, as well as ®brinogen binding to GP IIb ± IIIa (Haimovich et al., 1993) . We further demonstrated that Tec was translocated to cytoskeleton in a manner dependent on platelet aggregation upon stimulation with TRAP (Figure 4) . The current understanding of integrin-mediated signaling is that integrins and cytoskeletons form a signal transduction complex which anchors and compartmentalizes various kinases and other signaling molecules (Clark and Brugge, 1995) . Based on the notion, we consider that Tec participates in integrin-mediated signaling as a component of integrin-cytoskeleton complex.
One of the characteristics in the regulation of Tec in integrin-mediated signaling is that actin polymerization was not required for tyrosine phosphorylation ( Figure  5 ) and translocation of Tec to cytoskeleton (data not shown), which distinctively contrasts with Syk (Clark et al., 1994a; Tohyama et al., 1994) and FAK (Lipfert et al., 1992) ; tyrosine phosphorylation of these two kinases and translocation of Syk kinase to cytoskeleton have been reported to be dependent on actin polymerization. Thus, we consider that Tec becomes associated with integrin-cytoskeleton complex independent of actin polymerization. In other words, there should be a molecule which anchors Tec to integrincytoskeleton complex.
In summary, we have demonstrated that G proteincoupled receptor-and integrin-mediated signalings induce tyrosine phosphorylation in Tec in human blood platelets. These two types of the receptors, in addition to cytokine receptors, emerged as new signaling pathways which couple to tyrosine phosphorylation in Tec. The upstream and downstream pathways for Tec phosphorylation should be clari®ed in future experiments.
Materials and methods
Reagents
Apyrase, leupeptin, aprotinin, aspirin, cytochalasin D, phenylmethanesulfonyl¯uoride (PMSF), adenosine 5'-diphosphate (ADP), collagen (type I), and RGDS peptide were purchased from Sigma Chemical Co. (St Louis, MO). Human a-thrombin was purchased from Green Cross (Osaka, Japan). Thrombin receptor activating peptide (TRAP: SFLLRNPNDKYEPF) was from Calbiochem (La Jolla, CA). Human ®brinogen was from Serbio Laboratory (Gennevilliers, France). U46619 was from Cayman Chemical Co. (Ann Arbor, MI). Human recombinant thrombopoietin (TPO) was a gift from Kirin Brewery Co. (Tokyo, Japan). Sepharose CL-2B and Protein A-Sepharose CL-4B were purchased from Pharmacia Biotech (Uppsala, Sweden). ECL-immunoblotting detection reagents were from Amersham (Arlington Heights, IL). All other chemicals were of reagent or analytical grade.
Antibodies
Anti-FAK polyclonal and monoclonal antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA) and Transduction Laboratories (Lexington, KY), respectively. Anti-phosphotyrosine monoclonal antibody (4G10) was purchased from Upstate Biotechnology Inc. (Lake Placid, NY). Rabbit anti-Tec polyclonal antibody was prepared as described previously . Horseradish peroxidase (HRP)-conjugated antimouse or anti-rabbit immunoglobulin antibody were purchased from Amersham.
Solutions
Reaction buer: 137 mM NaCl, 2.7 mM KCl, 3.3 mM NaH 2 PO 4 , 1 mM MgCl 2 , 5.6 mM glucose, 0.1% (w/v) bovine serum albumin (BSA), 20 mM HEPES, pH 7.4. ACD solution: 2.2% (w/v) sodium citrate, 0.8% (w/v) citric acid and 2.2% (w/v) dextrose. Platelet lysing buer: 1% Triton X-100, 5 mM EGTA, 5 mM EDTA, 1 mM sodium orthovanadate, 50 mM Tris-HCl, pH 7.4, containing 20 mg/ ml leupeptin, 20 mg/ml aprotinin and 1 mM PMSF. Radioimmunoprecipitation assay (RIPA) buer: 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 1% sodium deoxycholate, 158 mM NaCl, 1 mM sodium orthovanadate, 5 mM EGTA, 10 mM Tris-HCl, pH 7.4, containing 20 mg/ml leupeptin, 20 mg/ml aprotinin, and 1 mM PMSF. Phosphate-buered saline (PBS): 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , pH 7.4. T-TBS (Tris-buered saline with Tween-20): 150 mM NaCl, 20 mM Tris-HCl, pH 7.4, containing 0.5% Tween-20. SDS sample buer: 1% SDS, 5% glycerol, 5% 2-mercaptoethanol (2-ME), 10 mM EGTA, 1 mM sodium orthovanadate, 0.002% bromophenol blue, 62.5 mM TrisHCl, pH 6.8. Stripping buer: 100 mM 2-ME, 2% SDS, 62.5 mM Tris-HCl, pH 6.7.
Preparation of gel-®ltrated platelets
Venous blood was drawn into a 1/7 the volume of ACD solution from healthy volunteers or a patient with type I Glanzmann's thrombasthenia with informed consent. Platelet-rich plasma (PRP) was prepared by centrifugation at 150 g for 10 min. In some experiments PRP was treated with 1 mM aspirin for 30 min at room temperature (RT). After adding 1/10 the volume of ACD solution, PRP was further centrifuged at 500 g for 20 min. The pellet was resuspended in minimum volume of the reaction buer with 10% ACD solution, and then gel-®ltrated on Sepharose CL-2B equilibrated with the reaction buer. Platelets eluting in the void volume were collected, and used immediately after adding 1 mM CaCl 2 .
Immunoprecipitation of signaling molecules
Gel-®ltrated platelets (0.5 ± 1610 9 /ml, 500 ml) were activated by various agonists at 378C under stirring conditions unless otherwise mentioned. The reaction was stopped by adding an equal volume of ice-cold 26 RIPA buer. The samples were kept on ice for 30 min, and insoluble materials were removed by centrifugation (at 12 000 g for 10 min at 48C). The lysates were precleared with 40 ml of 1 : 1 slurry of Protein A-Sepharose CL-4B in RIPA buer for 1 h at 48C. The precleared platelet lysates were reacted with anti-Tec or anti-FAK polyclonal antibody for 2 h at 48C. The immunocomplexes were precipitated with Protein A-Sepharose CL-4B (at 48C for 1 h), and washed three times with RIPA buer. The samples were resolved in 50 ± 40 ml of SDS sample buer and boiled for 5 min. In some experiments, platelet aggregation was concomitantly monitored with a lumiaggregometer (Model PAT-2A: Niko Bioscience, Tokyo, Japan) during platelet activation.
Platelet adhesion assay
Platelet adhesion to ®brinogen or collagen was assayed in 100 mm non-tissue culture-treated polystyrene plates (Iwaki Glass, Chiba, Japan). Plates were coated with ®brinogen (100 mg/ml in PBS) for 16 h or with collagen (50 mg/ml in 0.5% acetic acid) for 2 h at RT. After coating, plates were washed three times with PBS, blocked with BSA (5 mg/ml in PBS) for 2 h at RT, and washed again with PBS. BSA-coated plates were used as a control. Gel®ltrated platelets (2610 8 /ml) in 1.5 ml of the reaction buer were incubated in ®brinogen-or collagen-coated plates for 1 h at RT. After three washings with PBS containing 1 mM sodium orthovanadate, adherent platelets were rapidly lysed with 1 ml of ice-cold RIPA buer. As a negative control, nonadherent platelets recovered from BSA-coated plates were lysed by adding 26RIPA buer. The platelet lysates were used for immunoprecipitation experiments.
Preparation of platelet subcellular fractions
Platelets were lysed by adding 1/3 the volume of 36platelet lysing buer. The samples were kept on ice for 10 min, and then centrifuged at 10 000 g for 15 min at 48C. The supernatant was further centrifuged at 100 000 g for 3 h. The 10 000 g pellet, 100 000 g pellet and 100 000 g supernatant were de®ned as cytoskeleton (CSK), membrane skeleton (MSK) and soluble fraction (SOL), respectively. Samples for cytoskeleton and membrane skeleton were resolved in minimum volumes of sample buer, sonicated for 5 min, and boiled for 5 min for immunoblotting.
Immunoblotting
Proteins were separated by SDS polyacrylamide gel electrophoresis (SDS ± PAGE) and transferred to a nitrocellulose membrane (Hybound ECL: Amersham), which was blocked overnight with 5% BSA in T-TBS. The membrane was reacted with a speci®c antibody, washed with T-TBS, incubated with HRP-conjugated anti-immunoglobulin antibody, then developed using an ECL-immunoblotting detection kit. To detect FAK, anti-FAK monoclonal antibody was used. To reprobe the membrane with another antibody, the membrane was washed in the stripping buer for 30 min at 508C and blocked again overnight with 5% BSA in T-TBS.
